Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter treatment of eligible patients with tricuspid regurgitation
News | Structural Heart
Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives CE Mark

October 19, 2023 — Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system ...

Home October 19, 2023
Home
The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone recently, implanting its 250th congenital transcatheter heart valve.
News | Heart Valve Technology
St. Joseph's Children's Hospital Implants 250th Pulmonary Valve Without Open-Heart Surgery

October 17, 2023 — The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone ...

Home October 17, 2023
Home
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays
News | Structural Heart
UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound

October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which ...

Home October 12, 2023
Home
According to new research published in Mayo Clinic Proceedings, calculating the patient's mean arterial pressure (AugMAP) is a simple and effective way to identify those patients who may benefit from more aggressive treatment strategies.
News | Structural Heart
Mayo Clinic Researchers Develop Calculation to Identify High-risk Moderate Aortic Stenosis Patients

October 5, 2023 — Mayo Clinic researchers have developed a calculation that can help identify moderate aortic stenosis p ...

Home October 05, 2023
Home
News | Heart Failure
JACC Issues Scientific Statement Exploring Impact of dLVAD on Quality of Life for HF Patients

October 5, 2023 — A newly-issued "Scientific Statement on Durable Mechanical Circulatory Support" in the October issue ...

Home October 04, 2023
Home
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
News | Heart Valve Technology
Minneapolis Heart Institute Foundation Launches the PROGRESS Clinical Trial to Examine the Safety and Effectiveness of Transcatheter Valve Replacement in Patients with Moderate, Calcific Aortic Stenosis

September 20, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home September 20, 2023
Home
New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety
News | Left Atrial Appendage (LAA) Occluders
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval ...

Home September 07, 2023
Home
The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser Permanente research shows
News | Structural Heart
Large Kaiser Permanente Study Could Lead to Better Management for Patients with Aortic Stenosis

September 6, 2023 — The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser ...

Home September 06, 2023
Home
Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device, recently announced the completion of its FDA-approved Early Feasibility Study for the high-risk percutaneous coronary intervention (HR-PCI) indication.
News | Cardiovascular Clinical Studies
Magenta Medical Completes Enrollment to Early Feasibility Study for World’s Smallest Heart Pump

September 6, 2023 — Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device ...

Home September 06, 2023
Home
40-site pilot program across US, UK, and Europe aims to introduce cutting edge AI solutions into the clinical environment to improve patient care and efficiency
News | Artificial Intelligence
Medtronic Announces First Patient Treated in Global Collaboration with Cydar Medical

August 23, 2023 — Medtronic is announcing the first patient treated in a global pilot program in collaboration with Cyda ...

Home August 23, 2023
Home
As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.
Blog | Enterprise Imaging
BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...

Home August 10, 2023
Home
India clinical trial commences with first 30 cases
News | Heart Valve Technology
First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve

August 2, 2023 —  Foldax, Inc., a leader in the development of innovative, polymer heart valves, today announced that ...

Home August 02, 2023
Home
Here is a look at what DAIC viewers were reading during the month of July
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
What Viewers Were Reading in July

Here is a look at what DAIC viewers were reading during the month of July:


1. Lessons Learned from World’s First ...

Home August 01, 2023
Home
The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)
News | Heart Valve Technology
FDA Issues Update on Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration

July 31, 2023 — Today, the U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 ...

Home July 31, 2023
Home
Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients who have undergone transcatheter aortic valve replacement (TAVR)
News | Stents
Abiomed Recalls All Impella Left Sided Blood Pumps for Risk of Motor Damage After Contact with Transcatheter Aortic Valve Replacement (TAVR) Stent

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

Home July 27, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now